相关实验视频

Updated: Sep 15, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

血管内皮卡德林功能障碍:高血压非叶片内脑出血的预测因素

Tondi Maspian Tjili¹, Julius July², Eryati Darwin³

¹Department of Neurosurgery, Arifin Achmad National Hospital, Pekanbaru, Indonesia.

Surgical neurology international

|July 14, 2025

概括

在高血压患者中,血管内皮卡德林 (VE-cadherin) 的较低水平可能预测非叶膜内脑出血 (ICH) 的风险. VE-cadherin对于血管完整性至关重要,其缺乏与增加ICH风险有关.

科学领域:

神经学神经学
心血管科学心血管科学
生物标志物研究生物标志物研究

背景情况:

内皮功能障碍是脑内出血 (ICH) 发病的核心原因.
血管内皮卡德林 (VE-cadherin) 对于保持血脑屏障完整性至关重要.
高血压通过炎症途径损害血管完整性,加剧了ICH风险.

研究的目的:

调查VE-cadherin水平与高血压患者非叶膜性ICH风险之间的关联.
确定VE-cadherin是否可以作为该人群中ICH风险的早期预测生物标志物.

主要方法:

一项为期12个月的研究,涉及80名高血压患者 (40名对照组,40名非叶膜性心脏病).
与酶相关的免疫吸收试验被用于量化VE-cadherin,干扰素玛和互白素-17.
接收器操作特征分析确定了VE-cadherin切割值,回归建模评估了ICH风险关联.

主要成果:

确立了一个VE-cadherin切线400.8 pg/dL.
较高的VE-cadherin水平独立地与非叶膜ICH的几率降低有关.
在回归分析中,VE-cadherin成为唯一具有统计学意义的生物标志物.

结论:

降低VE-cadherin水平与非叶膜ICH的发展有关.
测量VE-cadherin显示了其作为预测生物标志物的潜力,用于识别高风险高血压患者.
需要进一步的研究来证实VE-cadherin在ICH预防策略中的临床实用性.

关键词:

粘附粘附粘附粘附粘附粘附粘附粘附差距差距的交叉点差距的交叉点在高血压的高血压.脑内出血脑内出血一次性中风,中风.血管内皮 - - 阴素

更多相关视频

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model

Published on: February 8, 2022

Non-invasive Assessment of Microvascular and Endothelial Function

Non-invasive Assessment of Microvascular and Endothelial Function

Published on: January 29, 2013

相关概念视频

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...